Supplementary

G1-or-G2
Continuous-G1/2-HE4 NS = nonsignificant p > 0.1. The final model with real-life clinical applicability is shown in bold with detailed description of the model where P(dMI) stands for the probability of having myometrial invasion ≥ 50%, age k =1 if patient is 60 years old or more (otherwise age k = 0), HE4ren k = 1 if HE4ren is ≥ 45 pmol/l (otherwise HE4ren k = 0), CA125 k = 1 if CA125 is ≥ 35 U/ml (otherwise CA125 k = 0). The probability of dMI as a function of total score is shown for various levels of probability.
* Cut-off values were calculated from ROC analysis and cut-offs with optimal sensitivity and specificity were further exploited for age and HE4ren (data not shown). In the case of CA125, ROC analysis revealed optimal cut-off values of 24.5 U/ml for any-grade patients and 26.0 U/ml for G1-or-G2 patients (data not shown). Thus, CA125 cut-off values 20 U/ml, 25 U/ml and 35 U/ml were tested in categorical models with optimal analytical efficacy for CA125 cut-off 35 U/ml (data not shown). Se = Sensitivity, Sp = Specificity, PPV = positive predictive value, NPV = negative predictive value, * optimal cut-off for MMCI training dataset. The cut-off value confirmed by validation sets is shown in bold.
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